Skip to main content
Clinical Trials/CTRI/2019/02/017432
CTRI/2019/02/017432Active, not recruitingPhase 2

A comparative study to evaluate the Rujahara(analgesic) effect of virechana karma and vaitarana basti in Amavata (rheumatoid arthritis)

Choudhary brahm prakash charak ayurveda sansthana0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients with clinical features of Amavata as described in Madhav Nidan.
  • Patients between the age group of 21 to 50 years.
  • Patients fulfilling the 2010 ACR-EULAR criteria for Rheumatoid Arthritis.

Exclusion Criteria

  • Patients having severe crippling bone deformities and severely damaged joint with bed ridden patients.
  • Patients having any type of Arthropathy such as neoplasm of spine, Gout, Ankylosing spondylitis, Traumatic arthritis and pyogenic osteomyelitis and any other type of arthritis.
  • Patients having associated Cardiac disease, Tuberculosis, malignant hypertension, Impairment of Liver functions, Impairment of Renal functions, malignancy, HIV-AIDS etc.
  • Pregnant women and lactating mother.
  • Patients who develop secondary complication of RA e.g. Pleuro-pericardial diseases

Investigators

Sponsor
Choudhary brahm prakash charak ayurveda sansthana

Similar Trials